ACAD
31.4
+0.35
+1.13%
AEMD
0.24
-0.01
-3.57%
APRI
1.4
-0.03
-2.09%
ARNA
4.55
+0.04
+0.89%
ATEC
1.29
-0.02
-1.53%
CFN
59.4
-0.2
-0.34%
CNAT
6.06
+0.1
+1.68%
CRXM
0.21
+0.00
+0.05%
CYTX
0.48
+0.01
+2.08%
DXCM
60.79
-0.21
-0.34%
GNMK
13.34
+0.03
+0.23%
HALO
14.73
+0.14
+0.96%
ILMN
201.17
+1.17
+0.58%
INNV
0.21
+0.01
+4.95%
INO
8.5
0.00
0.00%
ISCO
0.06
0.00
-3.23%
ISIS
70.4
+0.54
+0.77%
LGND
58.47
+1.44
+2.52%
LPTN
2.85
0.00
0.00%
MBVX
1.05
0.00
0.00%
MEIP
3.88
+0.02
+0.52%
MNOV
3.82
+0.05
+1.33%
MRTX
21.06
-0.23
-1.08%
MSTX
0.44
+0.01
+2.09%
NBIX
34.84
+0.49
+1.43%
NUVA
46.93
-0.37
-0.78%
ONCS
0.37
+0.00
+1.10%
ONVO
6.71
+0.02
+0.30%
OREX
5.34
-0.01
-0.19%
OTIC
31.79
+0.22
+0.70%
QDEL
24.37
-0.1
-0.41%
RCPT
115.24
+2.53
+2.24%
RGLS
18.75
+0.17
+0.93%
RMD
62.85
-0.18
-0.29%
SCIE
0.01
0.00
-9.60%
SPHS
0.47
0.00
0.00%
SRNE
10.93
+0.15
+1.39%
TROV
6.02
+0.19
+3.26%
VICL
1.05
+0.01
+0.48%
VOLC
17.97
+0.01
+0.06%
ZGNX
1.4
+0.03
+2.19%
Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

The Celsius Quiz this week – did you choose the right career?

September 3, 2014 – 8:18 am | Edit Post

This week’s Celsius quiz will help you answer the question if you picked the right career.

AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

September 3, 2014 – 4:56 am | Edit Post
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

It’s been a topsy-turvy few years for Infinity Pharmaceuticals. The Cambridge, MA-based company is well behind a few others, whose rival blood cancer drugs that have already made it to market, and…

[[Click headline to continue reading.]]

AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

September 3, 2014 – 4:56 am | Edit Post
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

It’s been a topsy-turvy few years for Infinity Pharmaceuticals. The Cambridge, MA-based company is well behind a few others, whose rival blood cancer drugs that have already made it to market, and…

[[Click headline to continue reading.]]

AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

September 3, 2014 – 4:56 am | Edit Post
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

It’s been a topsy-turvy few years for Infinity Pharmaceuticals. The Cambridge, MA-based company is well behind a few others, whose rival blood cancer drugs that have already made it to market, and…

[[Click headline to continue reading.]]

Feds Provide Funding, Expertise to Advance ZMapp Drug for Ebola

September 2, 2014 – 6:37 pm | Edit Post
Feds Provide Funding, Expertise to Advance ZMapp Drug for Ebola

The U.S. Department of Health and Human Services said today it would provide its expertise and as much as $42.3 million to help San Diego-based Mapp Biopharmaceutical accelerate development and…

[[Click headline to continue reading.]]

Feds Provide Funding, Expertise to Advance ZMapp Drug for Ebola

September 2, 2014 – 6:37 pm | Edit Post
Feds Provide Funding, Expertise to Advance ZMapp Drug for Ebola

The U.S. Department of Health and Human Services said today it would provide its expertise and as much as $42.3 million to help San Diego-based Mapp Biopharmaceutical accelerate development and…

[[Click headline to continue reading.]]

Feds Provide Funding, Expertise to Advance ZMapp Drug for Ebola

September 2, 2014 – 6:37 pm | Edit Post
Feds Provide Funding, Expertise to Advance ZMapp Drug for Ebola

The U.S. Department of Health and Human Services said today it would provide its expertise and as much as $42.3 million to help San Diego-based Mapp Biopharmaceutical accelerate development and…

[[Click headline to continue reading.]]

Isis heart drugs get good news

September 2, 2014 – 2:06 pm | Edit Post

Carlsbad biotech Isis announces progress with two of its flagship heart drugs.

Isis heart drugs get good news

September 2, 2014 – 2:06 pm | Edit Post

Carlsbad biotech Isis announces progress with two of its flagship heart drugs.

Enzyme Controlling Metastasis of Breast Cancer Identified

September 2, 2014 – 12:18 pm | Edit Post
Enzyme Controlling Metastasis of Breast Cancer Identified

Researchers at the University of California, San Diego School of Medicine have identified an enzyme that controls the spread of breast cancer. The findings, reported in the current issue of PNAS, offer hope for the leading cause of breas…